A retrospective analysis of the safety and activity of Lutetium-177-PSMA radionuclide treatment in heavily-pretreated men with metastatic castration-resistant prostate cancer

Category Primary study
JournalEuropean Urology, Supplements
Year 2019
This article has no abstract
Epistemonikos ID: 49b1ecd9582108ad84d503cfa667d1efdfbd30cb
First added on: Feb 11, 2025